目的:代谢功能障碍相关的脂肪性肝病(MASLD)增加了心血管风险。在资源有限的拉丁美洲地区,确定用于早期MASLD检测的有效生物标志物至关重要。我们旨在评估16种生物标志物对墨西哥个体MASLD的诊断功效。
方法:在这项横断面和分析研究中,使用振动控制瞬时弹性成像评估脂肪变性.MASLD是根据国际标准定义的。评估的生物标志物包括:内脏脂肪(VF),腰围(WC),腰高比(WHtr),腰臀比(WHr),内脏脂肪指数(VAI),肝脏脂肪变性指数(HSI)身体质量指数(BMI),稳态模型评估(HOMA),体重调整腰围指数(WWI),脂质积累产物(LAP),尿酸-肌酐比(UACR),甘油三酯-葡萄糖指数(TyG)及其变体TyG-WC,TyG-HDL,TyG-BMI,TyG-WHTR.
结果:161名参与者被纳入,其中122人符合MASLD标准(56%的女性,年龄53.9岁[47.5-64])和39岁是健康对照(76%的女性,52岁[45-64])。MASLD生物标志物的AUROC为:TyG-WC(0.84),LAP(0.84),TyG-BMI(0.82),TyG-WHTR(0.80),WC(0.78),TyG(0.77),WHTR(0.75),BMI(0.76),VF(0.75),恒生指数(0.75),TyG-HDL(0.75),WHr(0.72),VAI(0.73),UA/CR(0.70),HOMA(0.71),和一战(0.69)。观察到基于性别的差异。在调整社会人口统计学变量后,TyG-WC指数是MASLD的最佳预测因子。
结论:结论:我们的结果强调了几种非侵入性生物标志物在墨西哥人群中进行MASLD评估的潜力,强调性别之间诊断效能和临界值的差异。调整后,TyG-WC是最好的MASLD预测因子。
OBJECTIVE: Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) poses a heightened cardiovascular risk. Identifying efficient biomarkers for early MASLD detection in resource-limited Latin American regions is crucial. We aimed to evaluate the diagnostic efficacy of sixteen biomarkers for MASLD in Mexican individuals.
METHODS: In this cross-sectional and analytical
study, steatosis was assessed using vibration-controlled transient elastography. MASLD was defined according to international standards. Assessed biomarkers included: Visceral Fat (VF), Waist Circumference (WC), Waist-Height Ratio (WHtr), Waist-Hip Ratio (WHr), Visceral Adiposity Index (VAI), Hepatic Steatosis Index (HSI), Body Mass Index (BMI), Homeostatic Model Assessment (HOMA), Weight-Adjusted-Waist Index (WWI), Lipid Accumulation Product (LAP), Uric Acid-Creatinine Ratio (UACR), Triglyceride-Glucose Index (TyG) and its variants TyG-WC, TyG-HDL, TyG-BMI, TyG-WHtr.
RESULTS: 161 participants were included, of which 122 met MASLD criteria (56 % women, age 53.9 years [47.5-64]) and 39 were healthy controls (76 % women, age 52 [45-64]). The AUROCs of the biomarkers for MASLD were: TyG-WC (0.84), LAP (0.84), TyG-BMI (0.82), TyG-WHtr (0.80), WC (0.78), TyG (0.77), WHtr (0.75), BMI (0.76), VF (0.75), HSI (0.75), TyG-HDL (0.75), WHr (0.72), VAI (0.73), UA/CR (0.70), HOMA (0.71), and WWI (0.69). Sex-based differences were observed. After adjusting for sociodemographic variables, the TyG-WC index was the best predictor of MASLD.
CONCLUSIONS: In conclusion, our results underscore the potential of several noninvasive biomarkers for MASLD assessment in a Mexican population, highlighting variations in diagnostic efficacy and cut-off values between sexes. After adjusting, TyG-WC was the best MASLD predictor.